MNPR Operating Cash Flow Growth

Monopar Therapeutics Inc · Operating Cash Flow Growth

MNPR logo

MNPR Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-33085.60%
MNPR TTM Cash from Operations YoY % (-119.94% → -33085.60%)
High-resolution chart · PNG

MNPR operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Monopar Therapeutics Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
-33,085.5966%
3.8432%
-90.522%
-81.9612%
-43.9235%
-43.7609%
18.5047%
21.8353%
12.8461%
-3.6329%
-9.3693%
3.8028%
-1.4898%
10.936%
1.8081%
-21.2835%
-30.9685%
-43.3275%
-56.9492%
-59.5536%
-72.9469%
-73.9524%
-54.4987%
-33.0408%
-11.1823%
-2.3878%
-4.5353%
-3.2634%
14.3262%
1.6305%
-9.8684%
-30.6531%
-175.5812%
-150.2503%
-119.9395%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.